Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions.
about
Risk factors for relapse after allogeneic transplantation in acute myeloid leukemiaTreatment of Acute Myeloid Leukemia in Adolescent and Young Adult PatientsReduced-intensity and myeloablative conditioning allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome: a meta-analysis and systematic reviewProphylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation.Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients.Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity.Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation.Reduced-intensity conditioning hematopoietic stem cell transplantation: looking forward to an international consensusMulticentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.Protein dysregulation in graft versus host disease.Systematic review of health state utility values for acute myeloid leukemia.Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete reEfficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia.Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia
P2860
Q26771438-686414F8-BF87-4750-B0BC-2FE87C228B9BQ26799609-77297CA3-55F0-4B90-98C2-0F763E9B519EQ34770016-31C361B7-8DE3-441C-9112-56B16B5272F0Q35100974-CBB15AA2-D55C-41E7-B655-56DB06180496Q36264692-C43E5F16-7608-43BE-ADB8-2E93D951F4CAQ36914475-FC56C0A4-AD7F-42E1-8548-FA5CA5420755Q36957716-19234689-6491-4F56-B2E4-86714346ADE9Q37362603-ACD7E6F2-565E-4DBE-B6F4-0F0E7B43CCD8Q38434710-3AF62715-7326-4394-8C84-CEFBE0C40904Q38544314-9BDAD074-19DF-4B65-BF1A-F296D7D47BE0Q40725017-9E6A596C-F88A-4022-910D-449A216F05E7Q40777838-A25443A9-DBA8-4AF9-8A47-27896BB8E9A6Q49228781-F49C0494-4031-4C8B-ACE6-3AE72B1AD10FQ49780236-B76BE169-0185-4541-817C-5F275DB1D3FBQ54275690-38CC1AB6-2F5D-4761-928E-EDE0ED010542Q55263365-4BD57D83-8A84-41E9-8405-CE0A09F29A94Q58580432-20A0877B-5200-4AD2-BD08-41936D477E29
P2860
Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Allogeneic hematopoietic cell ...... in 2013 and future directions.
@en
type
label
Allogeneic hematopoietic cell ...... in 2013 and future directions.
@en
prefLabel
Allogeneic hematopoietic cell ...... in 2013 and future directions.
@en
P2093
P2860
P356
P1476
Allogeneic hematopoietic cell ...... in 2013 and future directions.
@en
P2093
Abraham S Kanate
Marcelo C Pasquini
Mehdi Hamadani
Parameswaran N Hari
P2860
P356
10.4252/WJSC.V6.I2.69
P577
2014-04-01T00:00:00Z